Developmental Funds

摘要：在当前的赠款期内，CCSG发展基金与以下项目结合使用： 慈善基金，通过支持试点项目，促进新墨西哥大学癌症中心的战略优先事项， 招聘3名新教师和一名特殊人群调查员，珂赛特惠勒，博士。的 UNMCC试点赠款计划旨在加强多学科和跨学科癌症合作 研究;促进癌症中心共享资源的使用，为校外赠款生成初步数据 申请;支持早期阶段，制药商发起的临床试验;为毕业生提供匹配支持 学生和博士后。新墨西哥州大学以及我们联合会的所有UNCC成员 合作伙伴（Lovelace呼吸研究所）有资格申请。所有的拨款决定都是由 CCSG高级领导层在由Alan Tomkinson博士组织的正式，严格的同行评审过程后， 基础研究副主任，在癌症中心研究管理局的支持下。成果 通过请求年度进展来跟踪来自试点赠款的（出版物、赠款、专利、临床试验） 奖励终止后的5年报告。自2015年以来，107项试点赠款涉及50多个UNCC 成员已被授予。这笔投资的719，625美元来自CCSG发展基金， 来自癌症中心慈善基金的研究成果在同行评审期刊上发表了44篇论文， 一个NCI K 07补助金给初级教师，11个NIH R 01赠款，两个NIH R21赠款，一个NIH P01补助金和16个赠款 其他国家供资机构的直接费用返还额为26 027 334百万美元（费用总额为44 829 820美元）。在 此外，美国癌症协会的机构研究基金支持新教员指导的试点项目 建立以癌症为重点的研究职业，包括行为研究的职业。在下一个资助期， 我们建议将CCSG发展基金用于：1）在研究领域招聘教师， 联合国儿童基金会高级领导层; 2）为促进多学科和跨学科合作的试点赠款提供资金 实验室癌症研究、临床癌症研究、人群癌症研究， 癌症健康差异，以及涉及学术界和社区伙伴关系的集水区研究， 社区参与战略; 3）支持特殊人群工作人员调查员，珂赛特惠勒，博士， 世卫组织将重点关注全州、国家和全球癌症预防研究倡议的战略发展; 和4）支持临床研究人员和早期临床研究者，他们将在以下方面发挥关键作用： 开发和实施该中心的临床活动，扩大临床试验的组合， 与UNMCCC服务的患者人群相匹配，并增加临床试验的累积。

ABSTRACT: In the current grant period, CCSG Developmental Funds have been used in combination with philanthropic funds to promote the strategic priorities of the UNM Cancer Center by supporting pilot projects, the recruitment of 3 new faculty and a Special Populations Staff Investigator, Cosette Wheeler, PhD. The UNMCC pilot grant program was designed to; enhance collaborative multidisciplinary and transdisciplinary cancer research; promote the use of Cancer Center Shared Resources to generate preliminary data for extramural grant applications; support early phase, investigator-initiated clinical trials; provide matching support for graduate students and postdoctoral fellows. All UNMCC members at New Mexico Universities, as well as at our consortium partner (Lovelace Respiratory Research Institute) were eligible to apply. All funding decisions were made by the CCSG senior leadership after a formal, rigorous peer review process organized by Alan Tomkinson, PhD, Associate Director for Basic Research, with support from the Cancer Center Research Administration. Outcomes (publications, grants, patents, clinical trials) from the pilot grants are tracked by requesting annual progress reports for 5 years after the award has terminated. Since 2015, 107 pilot grants involving more than 50 UNMCC members have been awarded. This investment of $719,625 from CCSG Developmental funds and $2,096,148 from Cancer Center philanthropic funds resulted in 44 publications in peer-reviewed journals and the award of one NCI K07 grant to a junior faculty, 11 NIH R01 grants, two NIH R21 grants, one NIH P01 grant, and 16 grants from other national funding agencies, a return of $26,027,334 million in direct costs ($44,829,820 total costs). In addition, an American Cancer Society Institutional Research Grant supports mentored pilot projects by new faculty establishing cancer-focused research careers, including careers in behavioral research. In the next grant period, we are proposing to use CCSG Developmental funds to; 1) faculty recruitment in research areas identified by UNMCCC senior leadership; 2) fund pilot grants that promote collaborative multidisciplinary and interdisciplinary research in laboratory-based cancer research, clinical cancer research, population-based cancer research, cancer health disparities, and catchment area studies involving academic-community partnerships and community engagement strategies; 3) support a Special Populations Staff Investigator, Cosette Wheeler, PhD, who will focus on strategic development of statewide, national, and global cancer prevention research initiatives; and 4) support a Clinical Staff Investigator and an Early Stage Clinical Investigator who will in play key roles in the development and implementation of the Center’s clinical activity, expanding a portfolio of clinical trials that are matched to the patient population served by the UNMCCC and increasing clinical trial accrual.